SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a ...

SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...
MediaNama

Meta Used ‘Playbook’ To Delay Action On Scam Ads, Internal Documents Reveal

Meta used an internal playbook to delay enforcement action on scam ads worldwide, internal documents that Reuters accessed ...
NERDBOT

Salesforce AI Governance Checklist: How Architects Can Eliminate Costly Pitfalls

Salesforce AI solutions have become central to enterprise strategy as businesses seek smarter ways to manage customer ...
The IslandOpinion

Why is transparency underfunded?

The RTI Commission has now confirmed what many suspected — although the RTI Act grants it independence to recruit staff, this ...
BMJ Open

Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre ...

Background Inflammatory bowel disease (IBD) patients in China exhibit critically low levels of physical activity, yet evidence for telemedicine-based aerobic exercise interventions remains scarce, ...